TrasGEX™: Phase 1 Study in Cancer Patients

NCT01409343 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: TrasGEX™

Sponsor

Glycotope GmbH

Collaborators

[object Object]